Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Telemedicine Practice Standards States Regulate: Consultation Requirements: Some states require live video or phone (not just messaging) Others allow asynchronous (message-based) consultations Documentation requirements vary Patient consent forms differ Prescribing Standards: What can be prescribed via telehealth Whether initial in-person visit required (rare for weight loss now) Documentation needed in medical record Follow-up requirements Examples of State Variations: More Restrictive States: May require video consultation (not just questionnaire) Additional documentation requirements More stringent informed consent Limitations on initial prescribing More Permissive States: Allow asynchronous consultations Streamlined documentation Fewer restrictions on telehealth prescribing Legitimate providers comply with each states specific requirements
Ads are running on TV and streaming, along with a large out-of-home campaign in New York City, including a full subway station takeover in Times Square.
44 potential PROMs were identified and taken forward to Stage 2
106.4 Development and Validation of the Postoperative Recovery Assessment in Lung Cancer (PRA_Lung): A Modular Patient-Reported Outcome Measure Cheng Lei 1 , Hongfan Yu 2 , Wen Zhou 2 , Qiuling Shi 2 1 Sichuan Cancer Hospital and Institute, Chengdu, China, 2 State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing, China Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :106.4 Aims This study aimed to develop and validate a modular patient-reported outcome measure (PROM) for assessing postoperative recovery in lung cancer patients, integrating symptom burden and functional interference domains while prioritizing patient-centered perspectives
Understanding potential interactions between magnesium supplementation and GLP-1 medications, as well as other commonly prescribed drugs, is essential for safe and effective treatment
NICE TA664 provides similar guidance for liraglutide 3 mg (Saxenda) in selected high-risk groups
US$ 28.75
US$ 21.72
US$ 20.73
US$ 26.54
